Bison Wealth’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,372
Closed -$479K 364
2024
Q3
$479K Sell
8,372
-767
-8% -$44K 0.08% 243
2024
Q2
$372K Hold
9,139
0.06% 287
2024
Q1
$372K Buy
9,139
+26
+0.3% +$975 0.06% 287
2023
Q4
$337K Sell
9,113
-3,030
-25% -$114K 0.06% 296
2023
Q3
$464K Sell
12,143
-7,900
-39% -$324K 0.09% 227
2023
Q2
$723K Buy
20,043
+171
+0.9% +$5.83K 0.13% 164
2023
Q1
$656K Buy
19,872
+480
+2% +$22.5K 0.2% 128
2022
Q4
$991K Sell
19,392
-791
-4% -$40.5K 0.32% 103
2022
Q3
$798K Buy
+20,183
New +$892K 0.31% 104

Other funds holding HALO

Bison Wealth's HALO Position: Q4 2024 in Review

Bison Wealth sold out of Halozyme (HALO) in Q4 2024, closing a stake of 8,372 shares — an estimated $479K sold.

Bison Wealth first reported a position in HALO in Q3 2022 and held it in 9 quarters. The position peaked at $991K in Q4 2022. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • Bison Wealth reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • Bison Wealth sold 8,372 Halozyme shares in Q4 2024, an estimated $479K.
  • Bison Wealth first reported a position in Halozyme in Q3 2022 and held it in 9 quarters.
  • Bison Wealth's Halozyme position peaked at $991K in Q4 2022.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Bison Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.